#shortage

1 article tagged #shortage.

Ready to compare providers? Take the 2-minute match quiz or see the cheapest GLP-1 options.

#2026 4 #503a 1 #503b 2 #FDA 1 #alternatives 1 #ban 1 #before-and-after 1 #beginners 2 #brand-name 3 #bridge-program 1 #cagrilintide 1 #cagrisema 1 #comparison 2 #compounded 8 #compounded-semaglutide 1 #compounded-tirzepatide 1 #compounding-ban 1 #copay 1 #cost 13 #coupon 1 #coverage 1 #diabetes 1 #diet 1 #dosage 1 #eli-lilly 3 #enforcement 1 #enrollment 1 #fact-check 1 #fda 3 #fda-approval 1 #flat-rate 1 #foundayo 7 #framework 1 #glp-1-patches 1 #glucose-monitors 1 #guide 1 #hhs 1 #hims 1 #how-to-get 1 #injectable 7 #injection 1 #insulin-resistance 1 #insurance 11 #ivy-rx 1 #ivyrx 1 #legality 1 #liraglutide 1 #medicaid 1 #medicare 5 #mounjaro 6 #news 2 #novo-nordisk 2 #oral-glp1 6 #oral-semaglutide 1 #orforglipron 4 #ozempic 7 #pcos 1 #pill 1 #pipeline 1 #policy 1 #prior-authorization 2 #regulation 2 #results 1 #rfk 1 #ro 1 #safety 3 #savings-card 1 #schedule 1 #semaglutide 19 #shortage 1 #side-effects 9 #supplements 1 #surmount 2 #surmount-5 1 #telehealth-enforcement 1 #telehealth-review 1 #timeline 1 #tirzepatide 18 #type-2-diabetes 1 #warning-letters 1 #wegovy 16 #wegovy-hd 1 #wegovy-pill 3 #weight-loss 26 #without-insurance 1 #zepbound 17

Editorial photograph illustrating the FDA compounded semaglutide enforcement crackdown

News Cost & InsuranceJune 19, 2026• 13 min read

Compounded Semaglutide Ban (2026): FDA Crackdown Explained + 4 Legal Switch Options

Updated June 29, 2026: FDA issued 30 warning letters to telehealth companies June 15 for illegally marketing compounded GLP-1s. 503B permanent exclusion comment period extended to July 30, 2026 (from June 29 via FR 2026-12937). FDA proposed April 30 to permanently remove semaglutide, tirzepatide, and liraglutide from the 503B Bulks List. 503A enforcement began April 22, 2025. 503B enforcement May 22, 2025. 3-4 million patients affected. Legal alternatives: compounded tirzepatide ($149-299/mo, medical-necessity only), Wegovy $349/mo via NovoCare, or Foundayo from $149/mo self-pay.

#shortage

Compounded Semaglutide Ban (2026): FDA Crackdown Explained + 4 Legal Switch Options

TrimRx

Gala

Embody

SkinnyRx